Myocardial iron overload in transfusion-dependent pediatric patients with acute leukemia

Pediatric Blood and Cancer

Volumn 51, Issue 5, 2008, Pages 691-693

  Lutz, K ^a,b   Von Komorowski, G ^a   Durken M ^a   Engelhardt, R ^c   Dinter, D J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Acute leukemia; Cardiac MRI; Myocardial iron overload

Indexed keywords

IRON;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD TRANSFUSION; BRAIN METASTASIS; BRAIN RADIATION; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHILD; CHILDHOOD LEUKEMIA; ERYTHROCYTE CONCENTRATE; FEMALE; FERRITIN BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HUMAN; IRON OVERLOAD; LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOTOMY; PRIORITY JOURNAL; SEPTICEMIA; TREATMENT OUTCOME;

ADOLESCENT; ANEMIA; ANTINEOPLASTIC AGENTS; BLOOD TRANSFUSION; CHILD; FEMALE; HEMOSIDEROSIS; HUMANS; LEUKEMIA; LIVER; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; VENTRICULAR FUNCTION, LEFT;

EID: 52249105080     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21663     Document Type: Article

References (13)

1. Hoffbrand AV. Diagnosing myocardial iron overload. Eur Heart J 2001;22:140-141.
2. Christoforidis A, Haritandi A, Tsitouridis I, et al. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients. J Pediatr Hematol Oncol 2006;28:311-315.
3. Borgna-Pignatti C, Rugolotto S, De Stafano P, et al. Survival and disease complications in thalassemia major. Ann NY Acad Sci 1988;850:227-231.
4. Aldouri MA, Wonke B, Hoffbrand AV, et al. High incidence of cardiomyopathy in beta-thalassemia patients receiving regular transfusion and iron chelation. Acta Haematologica 1990;84:113-117.
5. Nielsen P, Kordes U, Fischer R, et al. SQUID-biosusceptometry in iron overloaded patients with hematologic diseases. Klin Pädiatr 2002;214:218-222.
6. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
7. Wood JC, Tyszka M, Carson S, et al. Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood 2004;103:1934-1936.
8. Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol 2007;14:183-190.
9. Westwood M, Anderson LJ, Firmin DN, et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 2003;18:33-39.
10. Fischer R, Farrell D. Liver iron susceptometry. In: Andrae W, Nowak H, editors. Magnetism in medicine: A handbook. 2nd edition. Weinheim: Wiley-VCH; 2007, pp. 529-549.
11. Fung EB, Fischer R, Fagaly RL, et al. The New SQUID Biosusceptometer at Oakland: First year of experience. Neurol Clin Neurophysiol 2004:5.
12. Gandon Y. Iron and Liver. Available at: www.radio.univ-rennes1.fr. Accessed 2003: November 7.
13. Gandon Y, Guyader D, Heautot JF, et al. Hemochromatosis: Diagnosis and quantification with MR imaging. Radiology 1994;193:533-538.